![Sapna R. Srivastava](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sapna R. Srivastava
Directeur/Membre du Conseil chez
AURA BIOSCIENCES, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Dr. Sapna R.
Srivastava is an Independent Director at Alumis, Inc., an Independent Director at Nuvalent, Inc., an Independent Non-Executive Director at Aura Biosciences, Inc., an Independent Director at SQZ Biotechnologies Co. and a Strategic Advisor at BioPlus Acquisition Corp.
She is on the Board of Directors at Alumis, Inc., Nuvalent, Inc., Aura Biosciences, Inc., SQZ Biotechnologies Co., AsclepiX Therapeutics LLC and Trickle Up Program, Inc. Dr. Srivastava was previously employed as an Independent Director by Tourmaline Bio, Inc., an Independent Director by Innoviva, Inc., an Independent Director by Social Capital Suvretta Holdings Corp.
II, a Chief Financial Officer by eGenesis, Inc., an Independent Director by Talaris Therapeutics, Inc., a Chief Financial & Strategy Officer by Abide Therapeutics, Inc., a Chief Financial & Strategy Officer by Intellia Therapeutics, Inc., an Independent Director by MYOS Corp., an Analyst by Goldman Sachs & Co., an Analyst by Thomas Weisel Partners LLC, an Associate by JP Morgan Direct Corporate Finance, and a Research Analyst by Morgan Stanley & Co., Inc. She also served on the board at VelosBio, Inc. She received her undergraduate degree from St. Xavier's College (Mumbai) and a doctorate degree from New York University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUVALENT, INC. CLASS A 0,01 % | 16/06/2026 | 8 590 ( 0,01 % ) | 948 250 $ | 31/05/2026 |
AURA BIOSCIENCES INC 0,06 % | 11/06/2026 | 38 500 ( 0,06 % ) | 287 595 $ | 31/05/2026 |
ALUMIS INC. -.--% | 05/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Sapna R. Srivastava
| Sociétés | Poste | Début |
|---|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Directeur/Membre du Conseil | 23/10/2020 |
| AURA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/05/2021 |
| NUVALENT, INC. | Directeur/Membre du Conseil | 01/07/2021 |
| BIOPLUS ACQUISITION CORP. | Corporate Officer/Principal | - |
| ALUMIS INC. | Directeur/Membre du Conseil | 02/08/2022 |
AsclepiX Therapeutics LLC
 AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drug technology | Directeur/Membre du Conseil | 01/12/2019 |
Trickle Up Program, Inc.
 Trickle Up Program, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which provides poverty and vulnerability services | Directeur/Membre du Conseil | 01/01/2013 |
Anciens postes connus de Sapna R. Srivastava
| Sociétés | Poste | Fin |
|---|---|---|
| INNOVIVA, INC. | Directeur/Membre du Conseil | 19/05/2025 |
| TOUE BIOPAR | Directeur/Membre du Conseil | 26/10/2023 |
| ░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Sapna R. Srivastava
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
MYOS RENS Technology, Inc.
 MYOS RENS Technology, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes therapeutic products, nutritional supplements and other technologies | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company intended to develop drugs for serious diseases | Health Technology |
SQZ Biotechnologies Co.
 SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Thomas Weisel Partners LLC
 Thomas Weisel Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Trickle Up Program, Inc.
Trickle Up Program, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which provides poverty and vulnerability services | Commercial Services |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
St. Xavier's College (Mumbai)
 St. Xavier's College (Mumbai) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
eGenesis, Inc.
 eGenesis, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology company that provides organs and cells transplantation services | Health Services |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drug technology | Commercial Services |
VelosBio, Inc.
 VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research activities | Commercial Services |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
Social Capital Suvretta Holdings Corp. II
 Social Capital Suvretta Holdings Corp. II Financial ConglomeratesFinance Operates as blank check company | Finance |
BioPlus Acquisition Corp.
 BioPlus Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Jp Morgan Direct Corporate Finance
 Jp Morgan Direct Corporate Finance Investment ManagersFinance Functions as a private equity fund | Finance |
